Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK Pharma Stocks Under Pressure: Shares Drop Nearly 4 per cent Despite Diabetes and Obesity Drug Launch in UK With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment. Abhishek Wani / Friday, February 28, 2025 0 82 Article rating: 4.3 With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to strengthen its footprint in this segment. Read more
Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway Railway Kavach Company Bags New Order Worth Rs 325,33,00,000 From South Eastern Railway The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years. Kiran Shroff / Friday, February 28, 2025 1 1068 Article rating: 3.7 The stock gave multibagger returns of 167 per cent from its 52-week low, 700 per cent in 3 years and a whopping 4,300 per cent in 5 years. Read more
Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent. Kiran Shroff / Friday, February 28, 2025 0 230 Article rating: 3.1 The broader markets were in the red territory, with the BSE Mid-cap Index down 2.26 per cent and the BSE Small-cap Index down 2.33 per cent. Read more
UPI 3.0 – What’s Next for India’s Digital Payments Revolution? UPI 3.0 – What’s Next for India’s Digital Payments Revolution? How UPI 3.0 Will Transform Digital Payments with Offline Transactions, Global Reach, and Credit Access Pushkar Shinde / Friday, February 28, 2025 0 265 Article rating: 3.9 How UPI 3.0 Will Transform Digital Payments with Offline Transactions, Global Reach, and Credit Access Read more
Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News Small-Cap Pharma Stock Plunges as US Regulatory Letter Wipes Out Rs 938 Crore in Market Cap—But It’s Not All Bad News Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert. Abhishek Wani / Friday, February 28, 2025 0 122 Article rating: 5.0 Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises compliance concerns without halting operations or triggering an import alert. Read more